Sci Signal:FAK导致肿瘤免疫逃逸的机制

2017-12-11 药明康德 学术经纬

肿瘤非常善于逃避免疫系统的监察和抑制免疫系统活性,而粘着斑激酶 (focal adhesion kinase, FAK) 被认为在媒介肿瘤免疫逃逸中起到重要作用。

肿瘤非常善于逃避免疫系统的监察和抑制免疫系统活性,而粘着斑激酶 (focal adhesion kinase, FAK) 被认为在媒介肿瘤免疫逃逸中起到重要作用。

近日,德国爱丁堡大学 (University of Edinburgh) 的研究人员发表于《Sci Signal》上的一篇文章进一步揭示了FAK媒介肿瘤免疫逃逸的详细机制。他们发现在鳞状细胞癌 (squamous cell carcinoma, SCC) 的小鼠模型中,FAK能够激活细胞因子IL-33的表达。在细胞核中FAK与IL-33形成的复合体通过与一系列染色质修饰因子和转录因子的相互作用,会提高CCL5和ST2的表达和分泌。CCL5是一种激活免疫抑制调节性T细胞的趋化因子。而ST2是一种能够与IL-33相结合的诱饵受体 (decoy receptor),它能够阻断IL-33激发宿主免疫细胞的浸润。这项研究表明,阻断FAK-IL33信号通路可能帮助癌症患者的免疫系统发现和杀伤肿瘤。

原始出处:

Bryan Serrels,et al.,IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks.Sci Signal.05 Dec 2017:Vol. 10, Issue 508,eaan8355.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1793984, encodeId=10491e9398473, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640580, encodeId=31a1164058084, content=<a href='/topic/show?id=78a4e22688' target=_blank style='color:#2F92EE;'>#FAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7226, encryptionId=78a4e22688, topicName=FAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7722667526, createdName=12498a49m67暂无昵称, createdTime=Sun Jul 01 03:00:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036160, encodeId=00a2203616001, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 05 07:00:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268646, encodeId=9cda26864673, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 11 17:12:18 CST 2017, time=2017-12-11, status=1, ipAttribution=)]
    2018-01-07 yaanren
  2. [GetPortalCommentsPageByObjectIdResponse(id=1793984, encodeId=10491e9398473, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640580, encodeId=31a1164058084, content=<a href='/topic/show?id=78a4e22688' target=_blank style='color:#2F92EE;'>#FAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7226, encryptionId=78a4e22688, topicName=FAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7722667526, createdName=12498a49m67暂无昵称, createdTime=Sun Jul 01 03:00:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036160, encodeId=00a2203616001, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 05 07:00:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268646, encodeId=9cda26864673, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 11 17:12:18 CST 2017, time=2017-12-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1793984, encodeId=10491e9398473, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640580, encodeId=31a1164058084, content=<a href='/topic/show?id=78a4e22688' target=_blank style='color:#2F92EE;'>#FAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7226, encryptionId=78a4e22688, topicName=FAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7722667526, createdName=12498a49m67暂无昵称, createdTime=Sun Jul 01 03:00:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036160, encodeId=00a2203616001, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 05 07:00:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268646, encodeId=9cda26864673, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 11 17:12:18 CST 2017, time=2017-12-11, status=1, ipAttribution=)]
    2018-04-05 楚秀娟
  4. [GetPortalCommentsPageByObjectIdResponse(id=1793984, encodeId=10491e9398473, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640580, encodeId=31a1164058084, content=<a href='/topic/show?id=78a4e22688' target=_blank style='color:#2F92EE;'>#FAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7226, encryptionId=78a4e22688, topicName=FAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7722667526, createdName=12498a49m67暂无昵称, createdTime=Sun Jul 01 03:00:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036160, encodeId=00a2203616001, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 05 07:00:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268646, encodeId=9cda26864673, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 11 17:12:18 CST 2017, time=2017-12-11, status=1, ipAttribution=)]
    2017-12-11 天涯183

    非常好的文章.学习了

    0

相关资讯

PLoS ONE:microRNA-7降低FAK表达抑制乳腺癌转移

粘着斑激酶(FAK)是细胞外基质整合素信号以及细胞运动、细胞增殖和细胞存活的重要调节因子。FAK的表达在多种实体瘤中都被证实是明显增加的, FAK表达的增高于肿瘤转移以及患者预后差密切相关。 近日PLoS ONE刊出的一项研究发现miR-7能直接调节FAK的表达。相比于正常乳腺组织,miR-7的表达在恶性肿瘤组织中是减少的,并且miR-7的表达与乳腺癌患者转移成反比。 miR-7的表达上调会增

JCB:FAK帮助肿瘤细胞越狱

癌细胞都是越狱的高手,现在加州大学Moores癌症中心的科学家们揭示了它们的秘诀。研究显示,一种促进肿瘤生长的关键蛋白,可以帮助癌细胞突破组织的囚禁。文章发表在Journal of Cell Biology杂志上。 肿瘤细胞形成之后会受到周围组织的限制,只有进入血液或者淋巴管,才能转移到其他部位。研究显示,生长因子VEGF可以帮助肿瘤细胞,松开血管壁内皮细胞之间的联系